Foghorn Therapeutics Raises Approximately $110 Million
Positions company to further leverage strength of platform and advance programs through multiple data readouts and clinical value inflection points ...
Source: globenewswire.com
Karin Hellsvik News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Karin Hellsvik. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Karin Hellsvik Today - Breaking & Trending Today
Foghorn Therapeutics Raises Approximately $110 Million Through Registered Direct Offering to Advance Pipeline
Positions company to further leverage strength of platform and advance programs through multiple data readouts and clinical value inflection points Strengthens balance sheet with cash, cash...
Source: marketscreener.com
Foghorn Announces Pricing of Registered Direct Offering of Common Stock and Pre-Funded Warrants
CAMBRIDGE, Mass., May 20, 2024 -- Foghorn Therapeutics Inc. today announced the pricing of a registered direct offering of 12,743,039 shares of its common stock at a price of $5.51 per share,...
Source: marketscreener.com
Foghorn Therapeutics Provides First Quarter 2024 Financial and Corporate Update
Dose escalation in FHD-286 combination trial in AML continues to progress with clinical data expected in the second half of 2024; potential to be a first-in-class oral broad-based differentiation...
Source: marketscreener.com
Foghorn Therapeutics Presents New Preclinical Data on Potential First-in-Class BRM Selective Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Oncology Programs
First-in class BRM selective inhibitor FHD-909 demonstrated favorable tolerability and dose-dependent single agent activity in BRG1 mutated cancers preclinically; IND filing on track for Q2 2024 ...
Source: marketscreener.com